Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 16, 1984 - Issue sup43
Submit an article Journal homepage
59
Views
0
CrossRef citations to date
0
Altmetric
Miscellany

Future Aspects on the Clinical Use of Clindamycin: A Symposium Held at SAS Royal Hotel, Copenhagen, Denmark, April 6, 1984

Carl Erik Nord
&
Folke Nordbring
Pages 1-92 | Published online: 02 Jan 2015

References

  • Dale DO. Defects in host defense mechanisms in compromised patients. In: Rubin RH, Young LS, eds. Clinical approach to infection in the compromised host. New York: Plenum Medical Book Company, 35–74, 1981
  • Frøland SS. Infections with Pseudomonas aeruginosa in the compromised host. Scand J Infect Dis, Suppl. 29: 72–80, 1981
  • Schimpff SC, Young VM. Epidemiology and prevention of infection in the compromised host. In: Rubin RH, Young LS, eds. Clinical approach to infection in the compromised host. New York: Plenum Medical Book Company, 5–33, 1981
  • Rubin RH, Wolfson JS, Cosimi AB, Tolkoff-Rubin NE: Infection in the renal transplant recipient. Am J Med 70: 405–411, 1981
  • Elfenbein GJ, Saral R. Infectious disease during immune recovery after bone marrow transplantation. In: Allen JC, ed. Infection and the compromised host. Clinical correlations and therapeutic approaches. Second edition. Baltimore: Williams & Wilkins, 157–196, 1981
  • de Jongh CA, Schimpff SC. Prevention and management of infectious complications of cancer. In: Wiernik PH, ed. Supportive care of the cancer patient. New York: Futura Publishing Company, 75–108, 1983
  • Bodey GP, Bolivar R, Fainstein V. Infectious complications in leukemic patients. Semin Hematol 19: 193–226, 1982
  • Burrell MI, Hyson EA, Walker Smith GJ. Spontaneous clostridial infection and malignancy. Am J Radiol 134: 1153–1159, 1980
  • Fainstein V, Bodey GP, Fekety R. Pseudomembranous colitis due to cancer chemotherapy. J Infect Dis 143: 865–870, 1981
  • Sicles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med 135: 715–719, 1975
  • EORTC International Antimicrobial Therapy Project Group. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 137: 14–29, 1979
  • Wade JC, Schimpff SC. Approaches to therapy of bacterial infections in the granulocytopenic patient. In: Klastersky J, ed. Infections in cancer patients. New York: Raven Press, 105–129, 1982
  • Pizzo PA, Commers J, Cotton, D, Gress J, Hathorn J, Hiemenz J, Longo D, Marshall D, Robichaud KJ. Approaching the controversies in antibacterial management of cancer patients. Am J Med 76: 436–449, 1984
  • Anderson ET, Young LS, Hewitt WL. Antimicrobial synergism in the therapy of Gram-negative rod bacteremia. Chemotherapy 24: 45–54, 1978
  • Klastersky J, Daneau D, Swings G, Weerts D. Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. J Infect Dis 129: 187–193, 1974
  • Love LJ, Schimpff SC, Schiffer CA, Wiernik PH. Improved prognosis for granulocytopenic patients with Gram-negative bacteremia. Am J Med 68: 1–10, 1980
  • Wade JC, Schimpff SC, Wiernik PH. Antibiotic combination-associated nephrotoxicity in granulocytopenic patients with cancer. Arch Intern Med 141: 1789–1793, 1981
  • Stuart RK, Braine HG, Lietman PS, Saral R, Fuller DJ. Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients. A prospective, randomized, double-blind study. Am J Med 68: 876–885, 1980
  • Keating MJ, Lawson R, Grose W, Bodey GP. Combination therapy with ticarcillin and sulfamethoxazole-trimethoprim for infections in patients with cancer
  • Lau WK, Young LS, Black RE, Winston DJ, Linne SR, Weinstein RJ, Hewitt WL. Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients. Am J Med 62: 959–966, 1977
  • Klastersky J. The role of the new penicillins and cephalosporins in the management of infection in granulocytopenic patients. Schweiz Med Wschr, Suppl. 113: 64–69, 1983
  • Friis H, Hoffmann S, Hansen M, Mørk Hansen M, Justesen T, Nissen NI. Cefotaxime versus ampicillin, methicillin and netilmicin in combination for treatment of febrile episodes in patients with haematological malignancy. Acta Med Scand 213: 345–349, 1983
  • Joshi JH, Schimpff SC, Tenney JH, Newman KA, de Jongh CA. Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients? Am J Med 76: 450–457, 1984
  • Editorial. Granulocytopenia and septicaemia. Br Med J 281: 1091, 1980
  • Fauci AS, moderator. Acquired immunodeficiency syndrome: Epidemiology, clinical, immunologic, and therapeutic considerations. Ann Intern Med 100: 92–106, 1984
  • Curry WA. Human nocardiosis: A clinical review with selected case reports. Arch Intern Med 140: 818–826, 1980
  • Meyer RD. Legionella infections: A review of five years of research. Rev Infect Dis 5: 258–278, 1983
  • Wong, B. Parasitic diseases in immunocompromised hosts. Am J Med 76: 479–486, 1984
  • Wong KK, Hirsch MS. Herpes virus infections in patients with neoplastic disease. Diagnosis and therapy. Am J Med 76: 464–478, 1984
  • Rubin RH, Young LS, eds. Clinical approach to infection in the compromised host. New York: Plenum Medical Book Company, 1981

References

  • Mandell LA. The effects of antibacterial, antiviral and antifungal drugs on the phagocytic, microbicidal and chemotactic functions of the human polymorphonuclear leukocyte. Rev Infect Dis 4: 683–687, 1982
  • Solberg CO. Effect of antibiotics on the bactericidal activity of human leukocytes. Infection 6 ( Suppl. 1): 116–119, 1978
  • Forsgren A. Antimicrobial agents and host defence. Scand J Infect Dis, Suppl. 43: 24–33, 1984
  • Alexander JW, Good RA. Effect of antibiotics on the bactericidal activity of human leukocytes. J Lab Clin Med 71: 971–983, 1968
  • Easmon CSF. The effect of antibiotics on the intracellular survival of Staphylococcus aureus in vitro. Br J Exp Pathol 60: 24–28, 1979
  • Mandell GL. Interaction of intraleukocytic bacteria and antibiotics. J Clin Invest 52: 1673–1679, 1973
  • Mandell GL, Vest TK. Killing of intraleukocyte Staphylococcus aureus by rifampicin: in vitro and in vivo studies. J Infect Dis 125: 486–490, 1972
  • Prokesh RC, Hand WC. Antibiotic entry into polymorphonuclear leukocytes. Antimicrob Ag Chemother 21: 373–380, 1982
  • Klempner MS, Styrt B. Clindamycin uptake by human neutrophils. J Infect Dis 144: 472–479, 1981
  • Klempner MS, Styrt B. Alkalinization of the intralysosomal pH by clindamycin and its effects on neutrophil function. J Antimicrob Chemother 12 ( Suppl. C) 39–50, 1983
  • Elliot GR, Peterson PK, Verbrugh HA, Freiberg MR, Hoidal JR, Quie PG. Influence of subinhibitory concentrations of penicillin, cephalothin and clindamycin on Staphylococcus aureus growth in human phagocytic cells. Antimicrob Ag Chemother 22: 781–784, 1982
  • Gemmell CG, Shibl A. The control of toxin and enzyme biosynthesis in staphylococci by antibiotics. In: Jeljaszewicz J, ed. Staphylococci and staphylococcal diseases. Stuttgart: G. Fischer, 657–664, 1976
  • Gemmell CG, Amir MKA. Effects of certain antibiotics on the formation of cellular antigens and extracellular products by group A streptococci. In: Parker MT, ed. Pathogenic streptococci. Reedbooks, 67–68, 1978
  • Gemmell CG. Modification of the expression of an extracellular virulence factor (cytotoxin) of Clostridium difficile, following growth in the presence of clindamycin and vancomycin. In: Eickenberg H-U, Halm H, Opferkuch W, eds. The influence of antibiotics on the host-parasite relationship. Stuttgart: Springer-Verlag, 194–201, 1982
  • Unkles SE, Gemmell CG. Effect of clindamycin, erythromycin, lincomycin and tetracycline on growth and extracellular lipase production by propionibacteria in vitro. Antimicrob Ag Chemother 21: 39–43, 1982
  • Lorian V, De Freitas CC. The minimum antibiotic concentrations (MACs) of aminoglycosides and beta-lactam antibiotics for some gram-negative bacilli and gram-positive cocci. J Infect Dis 139: 599–603, 1979
  • Gemmell CG, Amir MKA. Antibiotic-induced changes in streptocci with respect to their interaction with human polymorphonuclear leukocytes. In: Nelson JD, Grassi C, eds. Current Chemo-Therapy and Infectious Diseases. Vol. II. Washington: Am. Soc. Microbiol., 810–812, 1980
  • Gemmell CG, Peterson PK, Schmeling D, Quie PG. Studies on the potentiation of phagocytosis of Streptococcus pyogenes by treatment with various antibiotics. Drugs Exptl Clin Res VIII: 235–240, 1982
  • Fox EM. M proteins of group A streptococci. Bact Rev 38: 57–86, 1974
  • Gemmell CG, Peterson PK, Schmeling D, Kim Y, Mathews J, Wannamaker L, Quie PG. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest 67: 1249–1257, 1981
  • Amir MKA. Changes in the pathogenicity of streptococci induced by certain antibiotics relevant to the host-parasite relationship. Ph.D. Thesis, University of Glasgow, 1980
  • Peterson PK, Verhoef J, Schmeling D, Quie PG. Effect of protein A on staphylococcal opsonization. Infect Immun 15: 760–764, 1977
  • Friedman H, Warren GH. Enhanced susceptibility of penicillin-resistant staphylococci to phagocytosis after in vitro incubation with low doses of nafcillin. Proc Soc Exp Biol Med 146: 707–711, 1974
  • Milatovic D. Effect of subinhibitory antibiotic concentrations on the phagocytosis of Staphylococcus aureus. Eur J Clin Microbiol 1: 97–101, 1982
  • Gemmell CG, O'Dowd A. Regulation of protein A biosynthesis in Staphylococcus aureus by certain antibiotics: its effect on phagocytosis by leukocytes. J Antimicrob Chemother 12: 587–597, 1983
  • Milatovic D, Braveny I, Verhoef J. Clindamycin enhances opsonization of Staphylococcus aureus. Antimicrob Ag Chemother 24: 413–417, 1983
  • Gemmell CG, Peterson PK, Schmeling D, Mathews J, Quie PG. Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes. Eur J Clin Microbiol 2: 327–334, 1983
  • Howard RJ, Soucy DM. Potentiation of phagocytosis of Bacteroides fragilis following incubation with clindamycin. J Antimicrob Chemother 12 ( Suppl. C): 63–68, 1983
  • Wade BH, Kasper DL, Mandell GL. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria. J Antimicrob Chemother 12 ( Suppl. C): 51–62, 1983
  • Noble WC. The production of subcutaneous staphylococcal skin lesions in mice. Br J Exp Pathol 46: 254–262, 1965
  • Gemmell CG. Effect of sub-growth inhibitory concentrations of antibiotics on experimental pyogenic infections. In: Current chemotherapy. American Society of Microbiology, Washington, D.C.: 512–514, 1978

References

  • Forsgren A, Schmeling D, Bank G. Effect of antibiotics on chemotaxis of human polymorphonuclear leucocytes in vitro. Infection 6, Suppl. S102–106, 1978
  • Bank G, Forsgren A. Many bacterial species are mitogenic for human blood B lymphocytes. Scand J Immunol 8: 347–354, 1978
  • Mandell GL. Interaction of intraleukocytic bacteria and antibiotics. J Clin Invest 52: 1673–1679 1973
  • Nelson RD, Quie PG, Simmons RL. Chemotaxis under agarose: A new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 115: 1650–1656, 1975
  • Forsgren A, Schmeling D. Effect of antibiotics on chemotaxis of human leukocytes. Antimicrob Agents Chemother 11: 580–584, 1977
  • Maaløe OU. On the relation between alexin and opsonin. Copenhagen: Munksgaard, 1946
  • Forsgren A, Gnarpe H. Tetracyclines and host defence mechanisms. Antimicrob Agents Chemother 3: 711–715, 1973
  • Forsgren A, Bank G. Influence of antibiotics on lymphocyte function in vitro. Infection 6 Suppl S91–97, 1978
  • Fauci AS, Pratt KR. Polyclonal activation of bone-marrow-derived lymphocytes from human peripheral blood measured by a direct plaque-forming cell assay. Proc Natl Acad Sci 73: 3676–3679, 1976
  • Judd KP, Trentin JJ. Cardiac transplantation in mice. I. Factors influencing the take and survival of heteropic grafts. Transplantation 11: 298–305, 1971
  • Svehag SE, Schilling W. Synergism between alloantibodies or Fab′2 and prednisone in the survival of murine split heart allografts. Transplantation 15: 345–347, 1973
  • Bellahsène A, Forsgren A. Effect of rifampin on the immune response in mice. Infect Immun 27: 15–20, 1980
  • Helium KB, Solberg CO. Human leucocyte migration: Studies with an improved skin chamber technique. Acta Pathol Microbiol Scand (C) 85: 413–419, 1977
  • Björksten B, Ray C, Quie PG. Inhibition of human neutrophil chemotaxis and chemiluminescence by amphotericin B. Infect Immun 14: 315–317, 1976
  • Chunn JC, Starr PR, Gilbert DN. Neutrophil toxicity of amphotericin B. Antimicrob Agents Chemother 12: 226–230, 1977
  • Goodhart GL. Effect of aminoglycosides on the chemotaxis response of human polymorphonuclear leukocytes. Antimicrob Agents Chemother 15: 540–542, 1977
  • Kahn AJ, Evans HE, Glass L, Kahn P. 15th Intersci. Conf. Antimicrob. Agents Chemother., Washington, DC., Abstract 65, 1975
  • Majeski JA, McClellan MA, Alexander JW. Evaluation of leukocyte chemotactic response in the presence of antibiotics. Surg Forum 26: 83–85, 1975
  • Majeski JA, McClellan MA, Alexander JW. Effect of antibiotics on the in vitro neutrophil chemotactic response. Am Surg 42: 785–788, 1976
  • Martin RR, Glenn W, Couch R, Knight V. Chemotaxis of human leukocytes. Responsiveness of Mycoplasma pneumoniae. J Lab Clin Med 81: 520–529, 1973
  • Martin RR, Warr G, Yeager M, Couch R, Knight V. Effect of tetracycline on chemotaxis. J Infect Dis 129: 110–116, 1974
  • Gnarpe H, Belsheim J, Persson S. Tetracycline interference with leukocyte chemotaxis. Infection 6, Suppl. 1, 98–101, 1978
  • Gnarpe H, Belsheim J. Tetracyclines and host defense mechanisms. Doxycyclinepolymethaphosphate sodium complex (DMSC) compared to doxycycline with regard to influence on some host defense mechanisms. Microbios 22: 45–49, 1978
  • Gnarpe H, Belsheim J. Drug interference with leukocyte chemotaxis: The influence of four aminoglycosides and polymixin B sulfate on leukocyte spontaneous and induced migration. Drugs Exptl Clin Res 5: 1–4, 1979
  • Belsheim J, Gnarpe H, Persson S. Tetracyclines and host defense mechanisms: Interference with leukocyte chemotaxis. Scand J Infect Dis 11: 141–145, 1979
  • Munoz J, Geister R. Inhibition of phagocytosis by aureomycin. Proc Soc Exp Biol Med 75: 367–370, 1950
  • Forsgren A, Schmeling D, Quie PG. Effect of tetracycline on the phagocytic function of human leucocytes. J Infect Dis 130: 412–415, 1974
  • Gnarpe H, Leslie D. Tetracyclines and host defense mechanisms. Doxycycline interference with phagocytosis of E. coli. Microbios 10A: 127–138, 1974
  • Forsgren A, Gnarpe H. The effect of antibacterial agents of the association between bacteria and leukocytes. Scand J Infect Dis, Suppl. 33: 115–120, 1982
  • Johnson JD, Hand WL, Francis JB, King-Thompson N, Corwin RW. Antibiotic uptake by alveolar macrophages. J Lab Clin Med 95: 429–438, 1980
  • Prokesch RC, Hand WL. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother 21: 373–380, 1982
  • Jacobs RF, Wilson CB. Activity of antibiotics in chronic granulomatous disease leukocytes. Pediatr Res 17: 916–919, 1983
  • Gmünder FK, Seger RA. Chronic granulomatous disease: Mode of action of sulfamethoxazole/trimethoprim. Pediatr Res 15: 1533–1538, 1981
  • Klempner MS, Styrt B. Clindamycin uptake by human neutrophils. J Infect Dis 144: 472–479, 1981
  • Serrou B, Solassol C, Joyeux H, Pujol H, Romieu C. Immunosuppressive effect of rifampicin. Transplantation 14: 654–655, 1972
  • Dajani BM, Kasik JE, Thompson JS. Effect of rifampicin on the immune response in guinea pigs. Antimicrob Agents Chemother 3: 451–455, 1973
  • Smith RG, Whang Peng J, Gallo RC, Levine P, Ting RC. Selective toxicity of rifamycin derivates for leukaemic human leukocytes. Nature N Biol 236: 166–171, 1972
  • Bassi L, Berardino L, Arioli V, Silvestri LG, Lignière ELC. Conditions for immunosuppression by rifampicin. J Infect Dis 128: 736–744 1973

References

  • Martin WJ, Gardner M, Washington JA. In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother 1: 148–158, 1972
  • Wilkins TD, Holdeman LV, Abramson IJ, Moore WEC. Standardized single-disc method for antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother 1: 451–459, 1972
  • Salaki JS, Black R, Tally FP, Kislak JW. Bacteroides fragilis resistant to clindamycin. Am J Med 60: 426–428, 1976
  • Dornbusch K, Olsson-Liljequist B, Nord CE. Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis. J Antimicrob Chemother 6: 207–216, 1980
  • Sato K, Matsuura Y, Inoue M, Mitsuhashi S. Properties of a new penicillinase type produced by Bacteroides fragilis. Antimicrob Agents Chemother 22: 579–584, 1982
  • Cuchural GJ Jr, Tally FP, Jacobus NV, Marsh PK, Mayhew JW. Cefoxitin inactivation by Bacteroides fragilis. Antimicrob Agents Chemother 24: 936–940, 1983
  • Yotsuji A, Minami S, Inoue M, Mitsuhashi S. Properties of novel beta-lactamase produced by Bacteroides fragilis. Antimicrob Agents Chemother 24: 925–292, 1983
  • Murray PR, Rosenblatt JE. Penicillin resistance and penicillinase production in clinical isolates of Bacteroides melaninogenicus. Antimicrob Agents Chemother 11: 605–608, 1977
  • Hackman AS, Williams TD. Influence of penicillinase production by strains of Bacteroides melaninogenicus and Bacteroides oralis on penicillin therapy of an experimental mixed anaerobic infection in mice. Arch Oral Biol 21: 385–389, 1976
  • Snydman DR, Tally FP, Knuppel R, Landrigan J, Gorbach SL, Bartlett JG. Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilities. J Antimicrob Chemother 6: 519–525, 1980
  • Timewell RM, Phillips I, Soderholm J, Nord CE. Isoelectric focusing of Bacteroides melaninogenicus group beta-lactamases. Antimicrob Agents Chemother 19: 700–704, 1981
  • Butler T, Tally FP, Gorbach SL, Malamy M. Transferable ampicillin resistance in B. fragilis. Clinical Research 28: 365, 1980
  • Rashtchian A, Dubes GR, Booth SJ. Transferable resistance to cefoxitin in Bacteroides thetaiotaomicron. Antimicrob Agents Chemother 22: 701–703, 1982
  • Tally FP, Cuchural GJ, Storey JR, Malamy MH. Intraspecies transfer of a cefoxitin resistance determinant in Bacteroides fragilis. Clinical Research 32: 385A, 1984
  • Tally FP, Cuchural GJ, Jacobus NV, Gorbach SL, Aldridge KE, Cleary TJ, Finegold SM, Hill GB, Iannini PB, McCloskey RV, O'Keefe JP, Pierson CL. Susceptibility of Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother 23: 536–540, 1983
  • McMurry L, Petrucci RE Jr, Levy SB. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc Natl Acad Sci USA 77: 3974–3977, 1980
  • Fayolle F, Privitera G, Sebald M. Tetracycline transport in Bacteroides fragilis. Antimicrob Agents Chemother 18: 502–505, 1980
  • Privitera G, Dublanchet A, Sebald M. Transfer of multiple antibiotic resistance between subspecies of Bacteroides fragilis. J Infect Dis 139: 97–101, 1979
  • Privitera G, Sebald M, Fayolle F. Common regulatory mechanism of expression and conjugative ability of a tetracycline resistance plasmid in Bacteroides fragilis. Nature 278: 657–659, 1979
  • Tally FP, Snydman DR, Shimell MJ, Malamy MH. Characterization of pBFTM10, a clindamycin-erythromycin resistance transfer factor from Bacteroides fragilis. J Bacteriol 151: 686–691, 1982
  • Tally FP, Shimell MJ, Carson GR, Malamy MH. Chromosomal and plasmid mediated transfer of clindamycin resistance in Bacteroides fragilis. In: Molecular Biology, Pathogenicity and Ecology of Bacterial Plasmids, Stuart B. Levy, Royston C. Clowes, Ellen L. Koernig, eds. New York: Plenum Publishing, 51–60, 1981
  • Rashtchian A, Dubes GR, Booth SJ. Tetracycline-inducible transfer of tetracycline resistance in Bacteroides fragilis in the absence of detectable plasmid DNA. J Bacteriol 150: 141–147, 1982
  • Smith CJ, Welch RA, Macrina FL. Two independent conjugal transfer systems operating in Bacteroides fragilis V479–1. J Bacteriol 151: 281–287, 1982
  • Rotimi VO, Duerden BI, Hafix S. Transferable plasmid-mediated antibiotic resistance in Bacteroides. J Med Microbiol 14: 359–370, 1981
  • Franke AE, Clewell DB. Evidence for a chromosome borne resistance transposon (Tn 916) in Streptococcus faecalis that is capable of “conjugal” transfer in the absence of a conjugative plasmid. J Bacteriol 145: 494–502, 1981
  • Brefort G, Magot N, Ionesco H, Sebald M. Characterization and transferability of Clostridium perfringens plasmids. Plasmid 1: 52, 1977
  • Smith CJ, Markowitz SM, Macrina FL. Transferable tetracycline resistance in Clostridium difficile. Antimicrob Agents Chemother 19: 997–1003, 1981
  • Tally FP, Sosa A, Jacobus NV, Malamy MH. Clindamycin resistance in Bacteroides fragilis. J Antimicrob Chemother 8 ( Suppl D): 43–48, 1981
  • Lai CJ, Weisblum B. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc Natl Acad Sci USA 68: 856, 1971
  • Cuchural GJ Jr, Tally FP, Jacobus NV, Gorbach SL, Aldridge K, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, Pierson C. Antimicrobial susceptibility of 1 292 isolates of the Bacteroides fragilis group in the United States: Comparison of 1981 with 1982. Antimicrob Agents Chemother 26: 145–148, 1984
  • Welch RA, Jones KR, Macrina FL. Plasmid—mediated of lincosamide-macrolide- and tetracycline resistance in Bacteroides. Plasmid 2: 261–268, 1979
  • Magot M, Fayolle F, Privitera G, Sebald M. Transposon-like structures in the Bacteroides fragilis MLS plasmid pIP410. Mol Gen Genet 181: 559–566, 1981
  • Welch RA, Macrina FL. Physical characterization of Bacteroides fragilis R plasmid pBF4. J Bacteriol 145: 867–872, 1981
  • Shimell MJ, Smith CJ, Tally FP, Macrina FL, Malamy MH. Hybridization studies reveal homologies between pBF4 and pBFTM10, two clindamycin-erythromycin resistance transfer plasmids of Bacteroides fragilis. J Bacteriol 152: 950–953, 1982
  • Marsh RK, Malamy MH, Shimell MJ, Tally FP. Sequence homology of clindamycin resistance determinants in clinical isolates of Bacteroides spp. Antimicrob Agents Chemother 23: 726–730, 1983
  • Yee MH, Guiney DG, Hasegawa P, Davis CE. The clinical significance of clindamycin-resistant Bacteroides fragilis. JAMA 248: 1860–1863, 1982
  • Bieluch VM, Malamy MH, Tally FP. Studies of a new clindamycin resistance determinant and transfer factor in B. fragilis (abstract no. 165). In: Program and abstracts of the 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Las Vegas, NV: October 1983

References

  • Dornbusch K, Nord CE, Olsson-Liljequist B. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis. Scand J Infect Dis 19: 17–25, 1979
  • Edson RS, Rosenblatt JG, Lee DT, McVey III EC. Recent experience with antimicrobial susceptibility of anaerobic bacteria. Increasing resistance to penicillin. Mayo Clin Proc 57: 737–741, 1982
  • Denys GA, Jerris RC, Svensson JM, Thornsberry C. Susceptibility of Propionibacterium acnes clinical isolates to 22 antimicrobial agents. Antimicrob Agents Chemother 23: 335–337, 1983
  • Marrie TJ, Haldane EV, Swantee CA, Kerr EA. Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin. Antimicrob Agents Chemother 19: 51–55, 1981
  • Ensminger PW, Counter FT, Thomas LJ, Lubbehusen PP. Susceptibility, resistance development and synergy of antimicrobial combinations against Clostridium difficile. Current Microbiol 7: 59–62, 1982
  • Aronsson B, Möllby R, Nord CE. Occurrence of toxin-producing Clostridium difficile in antibiotic-associated diarrhoea in Sweden. Med Microbiol Immunol 170: 27–35, 1981
  • Tally FP, Cuchural GJ, Jacobus NV, Gorbach SL, Aldridge KE, Cleany TJ, Finegold SM, Hill GB, Jannini PB, McCloskey RV, O'Keefe JP, Pierson CL. Susceptibility of the Bacteroides fragilis group in the United States 1981. Antimicrob Agents Chemother 23: 536–540, 1983
  • Skarin A, Holst E, Mårdh PA. Antimicrobial susceptibility of comma-shaped bacteria isolated from the vagina. Scand J Infect Dis, Suppl. 40: 81–84, 1983

References

  • Heineman HS, Braude AI. Anaerobic infection of the brain. Observations on eighteen consecutive cases of brain abscesses. Am J Med 35: 682–697, 1963
  • Browning GG, Picozzi G, Sweeney G, Calder IT. Role of anaerobes in chronic otitis media. Clin Otolaryngol 8: 47–51, 1983
  • Jokipii AM, Karma P, Ohala K, Jokipii L. Anaerobic bacteria in chronic otitis media. Arch Otolaryngol 103: 278–280, 1977
  • Sugita R, Kawamura S, Ichikawa G, Goto S, Fujimaki Y. Studies on anaerobic bacteria in chronic otitis media. Laryngoscope 91: 816–821, 1981
  • Lundberg C. Bacterial infections of the upper respiratory airways and beta-lactam antibiotics. Scand J Infect Dis Suppl. 42: 122–128, 1984
  • Lacny J. A comparison of oral therapy with clindamycin and penicillin G in common Gram-positive infections. Curr Ther Res 14: 26–30, 1972
  • Frederick J, Braude A. Anaerobic infection of the paranasal sinuses. N Engl J Med 290: 135–137, 1974
  • Carenfelt C, Lundberg C, Nord CE, Wretlind B. Bacteriology of maxillary sinusitis in relation to quality of retained secretion. Acta Otolaryngol (Stockholm) 86: 298–302, 1978
  • Lundberg C, Carenfelt C, Engquist S, Nord CE. Anaerobic bacteria in maxillary sinusitis. Scand J Infect Dis 19: 74–76, 1979
  • Engquist S, Lundberg C, Venge P. Effects of drainage in the treatment of acute maxillary sinusitis. Acta Otolaryngol (Stockholm) 95: 153–159, 1983
  • Neu HC. Clinical pharmacology of the antimicrobial agents for infections in the ear, nose and throat. Ann Otol Rhinol Laryngol 90: 2–7, 1981
  • Heimdahl A, Nord CE. Orofacial infections of odontogenic origin. Scand J Infect Dis 39: 86–91, 1983
  • Heimdahl A, von Konow L, Nord CE. Isolation of beta-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of orofacial infections. Arch Oral Biol 25: 689–692, 1980
  • Kannangara DW, Thadepalli H, McQuirter JL. Bacteriology and treatment of dental infections. Oral Surg 50: 103–109, 1980
  • Nord CE, Olsson-Liljequist B. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983. Scand J Infect Dis, Suppl. 43: 44–49, 1984
  • Aronsson B, Möllby R, Nord CE. Clostridium difficile and antibiotic associated diarrhoea in Sweden. Scand J Infect Dis 35: 53–58, 1982
  • Blatt IM. Chronic and recurrent inflammation about the salivary glands with special references to children. Laryngoscope 76: 917–933, 1966
  • Krippaehne WW, Hunt TK, Dunphy JE. Acute suppurative parotitis. Ann Surg 156: 251–257, 1962
  • Lundgren A, Kylén P, Ödkvist LM. Nosocomial parotitis. Acta Otolaryngol (Stockholm) 82: 275–278, 1976
  • Quayle AA, Whitmarsh VB. Mixed salivary levels of clindamycin following single dose oral administration. Br J Oral Surg 10: 24–29, 1972
  • Tunér K, Nord CE. Beta-lactamase-producing anaerobic bacteria in recurrent tonsillitis. J Antimicrob Chemother 10, Suppl A: 153–156, 1982
  • Flodström A, Hallander H. Microbiological aspects on peritonsillar abscesses. Scand J Infect Dis 9: 157–160, 1976
  • Lundberg C, Marklund G, Nord CE. Tinidazole in upper respiratory air-way infection. J Antimicrob Chemother 10, Suppl A: 177–184, 1984
  • Piccart M, Dor P, Klastersky J. Antimicrobial prohylaxis of infections in head and neck cancer surgery. Scand J Infect Dis, Suppl. 39: 92–96, 1983
  • Glaninger J. A meaningful antibiotic therapy of diseases of the ear, nose and throat in old age. Aktuel Gerontol 8: 493–502, 1978
  • Hedström SÅ. Clindamycin as an anti-staphylococcal agent—Indications and limitations. Scand J Infect Dis, Suppl. 43: 62–66, 1984
  • Heimdahl A, Nord CE. Effect of erythromycin and clindamycin on the indigenous human anaerobic flora and new colonization of the gastrointestinal tract. Eur J Clin Microbiol 1: 38–48, 1982

References

  • Schreiner A. Beta-lactams in lower respiratory tract diseases. Scand J Infect Dis, Suppl. 42: 129–134, 1984
  • Fransen H, Wolontis S. Infections with viruses, Mycoplasma pneumoniae and bacteria in acute respiratory illness. Scand J Infect Dis 1: 31–37, 1969
  • Fekety Jr, RF, Caldwell J, Grump D, Johnson J, Maxson W, Mulholland J, Thoburn R. Bacteria, viruses and mycoplasmas in acute pneumonia in adults. Am Rev Resp Dis 104: 499–507, 1971
  • Sullivan JR, Dowdle WR, Marine WM, Hierholzer JG. Adults pneumonia in a general hospital. Arch Intern Med 29: 935–942, 1972
  • Schreiner A, Digranes A. Bacteriology of acute respiratory tract infections. J Infect, Suppl. 2: 23–30, 1979
  • White RJ, Blainey AD, Jay Harrison K, Clarke SKR. Causes of pneumonia presenting to a district hospital. Thorax 36: 566–570, 1981
  • MacFarlane JT, Finch RG, Ward MJ, MacRae AD. Hospital study of adult community-acquired pneumonia. Lancet 2: 255–258, 1982
  • Matthay RA, Greene WH. Pulmonary infections in the immunocompromized patient. In: Putnam JS, Tuazon C, eds. The Medical Clinics of North America. Philadelphia: WB Saunders, 529–548, 1980
  • Dhawan VK, Thadepalli H. Clindamycin: A review of fifteen years of experience. Rev Infect Dis 4: 1133–1153, 1982
  • Hand WL, Thomson NK, Johnson JD. Alveolar macrophage (AM) interactions with antibiotics and bacteria. In: Proceedings of the 20th Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract 725. American Society of Microbiology, Washington, D.C., 1980
  • Prokesch RC, Hans WL. Antibiotic uptake by human polymorphonuclear leukocytes. In: Proceedings of the 20th Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract 726. American Society for Microbiology, Washington, D.C., 1980
  • Keusch GT, Present DH. Summary of a workshop on clindamycin colitis. J Infect Dis 133: 578–587, 1976
  • Cherumn CR, Magazine D, Margrove C, Klopman A, Stern L, Purpura D, Zaplach L. A comparative study of the treatment of presumed pneumococcal pneumonia: Parenteral penicillin and clindamycin with continuation on oral therapy. Curr Ther Res 17: 88–94, 1975
  • Weiss W, Flippin HF. Treatment of acute nonspecific primary lung abscess. Arch Intern Med 120: 8–11, 1967
  • Bartlett JG, Gorbach SL. Treatment of aspiration pneumonia and primary lung abscess. JAMA 234: 935–937, 1975
  • Brook I. Aspiration pneumonia in institutionalized children. A retrospective comparison of treatment with penicillin G, clindamycin and carbenicillin. Clinical Pediatrics 70: 117–122, 1981
  • Levison ME, Mangura CT, Lorber B, Abrutyn E, Levy RS, MacGregor RR, Schwartz AR. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med 98: 466–471, 1983
  • Bartlett JG, Gorbach SL. Penicillin or clindamycin for lung abscess. Editorial. Ann Intern Med 98: 546–548, 1983
  • Perlino CA. Metronidazole vs clindamycin treatment of anaerobic pulmonary infection. Arch Intern Med 141: 1424–1427, 1981

References

  • Magerlein BJ, Mirkenmeyer RD, Kagam, F. Chemical modification of lincomycin. Antimicrob Agents Chemother 5: 727–736, 1966
  • Lewis C, Clapp HW, Grady JE. In vitro and in vivo evaluation of lincomycin, a new antibiotic. Antimicrob Agents Chemother 2: 570–582, 1962
  • Cundliffe E. Antibiotics and polyribosomes. II. Some effects of lincomycin, spiramycin and streptogramin A in vivo. Biochemistry 8: 2063–2066, 1969
  • Leigh DA. Antibacterial activity and pharmacokinetics of clindamycin. J Antimicrob Chemother 7, Suppl. A: 3–9, 1981
  • Phillips I. Past and current use of clindamycin and lincomycin. J Antimicrob Chemother 7, Suppl. A: 11–18, 1981
  • Levine DP, Cushing RD, Jui J, Brown WJ. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit medical center. Ann Intern Med 97: 330–338, 1982
  • Cherubin CE, Nair SR. Clindamycin in infective endocarditis. JAMA 239: 626–627, 1978
  • Brun Y, Fleurette J, Forey F, Gonthier B. Antibiotic susceptibility of coagulase-negative staphylococci. Zbl Bakt, Suppl. 10: 137–145, 1981
  • Sabath LD. Antibiotics used in therapy of infections due to Staphylococcus aureus. In: Spitzy KH, Karrer K, eds. Staphylococcal infections. Proc 13th Int Congr Chemother 10: 34–40, 1983
  • Peterson PK, Quie PG, Kim Y, Wilkinson BJ, Verbrugh HA, Verhoef J. Recognition of Staphylococcus aureus by human phagocytes. Signals and disguises of the bacterial surface. Scand J Infect Dis, Suppl. 41: 67–76, 1983
  • Proctor RA, Hamill RJ, Mosher DF, Textor JA, Olbrant PJ. Effects of subinhibitory concentrations of antibiotics on Staphylococcus aureus interactions with fibronectin. J Antimicrob Chemother 12, Suppl. C: 85–95, 1983
  • Doran JE, Rissing JP. Influence of clindamycin on fibronectin-staphylococcal interactions. J Antimicrob Chemother 12, Suppl. C: 75–83, 1983
  • Holmes B, Quie PG, Windhorst DB, Pollara B, Good RA. Protection of phagocytized bacteria from the killing action of antibiotics. Nature 210: 1131–1132, 1966
  • Gmünder FK, Seger RA. Chronic granulomatous disease: Mode of action of sulfametoxazole/trimethoprim. Ped Res 15: 1533–1537, 1981
  • Klempner MS, Styrt B. Clindamycin uptake by human neutrophils. J Infect Dis 144: 472–479, 1981
  • Hand WL, King-Thompson NL, Steinberg TH. Interactions of antibiotics and phagocytes. J Antimicrob Chemother 12, Suppl. C: 1–11, 1983
  • Hugo H, Dornbusch K, Steiner G. Studies on the clinical efficacy serum levels and side effects of clindamycin phosphate administered intravenously. Scand J Infect Dis 9: 221–226, 1977
  • De Haan RM, Metzler CM, Schellenberg D, Vanderbosch WD. Pharmacokinetic studies of clindamycin phosphate. J Clin Pharmacol 13: 190–209, 1973
  • Norden CW, Kennedy E. Experimental osteomyelitis. II. Therapeutic trials and measurements of antibiotic levels in bone. J Infect Dis 124: 565–571, 1971
  • Feigin RD, Pickering LK, Anderson D, Keeney RE, Shackleford PG. Clindamycin treatment of osteomyelitis and septic arthritis in children. Pediatrics 55: 213–223, 1975
  • De Louvois J, Gortvai P, Hurley R. Antibiotic treatment of abscesses of central nervous system. Br Med J 2: 985–987, 1977
  • Walker WC, Douglas AC, Leckie WJH, Pines A, Grant IWB. Respiratory complications of influenza. Lancet 1: 449–454, 1958
  • Bagg R. Antibiotic treatment of staphylococcal pneumonia in adults. J Antimicrob Chemother 4: 297–299, 1978
  • De Louvois J, Hurley R. Inactivation of penicillin by purulent exudates. Br Med J 1: 998–1000, 1977
  • Sande MA, Johnson ML. Antimicrobial therapy of experimental endocarditis caused by 5. aureus. J Infect Dis 131: 367–375, 1975
  • Scheld WM, Johnson ML, Gerhardt EB, Sande MA. Clindamycin therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 21: 646–649, 1982
  • Watanakunakorn C. A general survey of antibiotic treatment of staphylococcal septicemia and endocarditis. Scand J Infect Dis, Suppl. 41: 151–157, 1983
  • Watanakunakorn C. Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin. Am J Med 60: 419–425, 1976
  • Rodriguez W, Ross S, Khan W, McKay D, Moskowitz P. Clindamycin in the treatment of osteomyelitis in children. A report of 29 cases. Am J Dis Child 131: 1088–1093, 1977
  • Paus B. Behandling av osteomyelit. Tidsskr Nor Lægeforen 89: 323–326, 1969
  • Eickhoff TC. Therapy of staphylococcal infection. In: Cohen, JO, ed. The staphylococci. New York, London, Sydney, Toronto: Wiley-Interscience, 517–541, 1972
  • Möllby R, Aronsson B, Nord CE. Ecological aspects on Clostridium difficile. In: Spitzy KH, Karrer K, eds. Proc 13th Int Congr Chemother 45: 8–11, 1983
  • Hedström SÅ. Recurrent anaerobic skin infections. Scand J Infect Dis 14: 241–242, 1982
  • Le Frock JL, Prince, RA, Klainer AS, Gainer RB, Kalis P. Parenteral clindamycin in the treatment of aerobic, anaerobic and mixed anaerobic-aerobic infections. Curr Ther Res 21: 289–314, 1977
  • Lidgren L, Hedström SÅ, Melin LO. Der infizierte Fuss. In: Murri A, ed. Der Fuss. Uelzen: Medizinisch Literarische Verlagsgesellschaft, 3: 237–240, 1981
  • Fass R. Treatment of mixed bacterial infections with clindamycin and gentamicin. J Infect Dis, Suppl. 135: 74–79, 1977

References

  • Moesgaard F, Larsen PN, Lykkegaard-Nielsen M, Hjortrup A. New approach to treatment of severe incisional abscesses following laparotomy. Dis Colon Rectum 26: 701–702, 1983
  • Howe CW. Technique of conversion and closure of postoperative septic wounds. Surg Gynecol Obstet 125: 123–126, 1967
  • Robson MC, Shaw RC, Heggers JP. The reclosure of postoperative incisional abscesses based on bacterial quantification of the wound. Ann Surg 171: 279–282, 1970
  • McIlrath DC, Heerden JA, Edis AJ, Dozois RR. Closure of abdominal incisions with subcutaneous catheters. Surgery 80: 411–416, 1976
  • Coles B, Heerden JA, Keys TF, Haldorson A. Incidence of wound infection for common general surgery. Surg Gynecol Obstet 154: 557–560, 1982
  • Elek SD, Conen PE. The virulence of Staphylococcus pyogenes for man. A study of the problems of wound infection. Br J Exp Pathol 38: 573–586, 1957
  • Blomstedt B, Osterberg B. Suture materials and wound infection. Acta Chir Scand 144: 269–274, 1978
  • Katz S, Izhar M, Mirelman D. Bacterial adherence to surgical sutures. A possible factor in suture induced infection. Ann Surg 194: 35–41, 1981
  • Sharp WV, Belden TA, King PH, Teague PC. Suture resistance to infection. Surgery 91: 61–63, 1982
  • Hunt PS, Francis JK, Peck G, Farrell K, Sali A. Tinidazole in the prevention of wound infection after elective colorectal surgery. Med J Aust 1: 107–109, 1979
  • Eykyn SJ, Jackson BT, Lockhart-Mummery HE, Phillips I. Prophylactic preoperative intravenous metronidazole in elective colorectal surgery. Lancet 2: 761–764, 1979
  • Wetterfors J, Höjer H. Prophylaxis with doxycycline in colorectal surgery. Scand J Gastroenterol 15, Suppl. 59: 11–16, 1980
  • Hughes ESR, McDermott FT, White A, Masterton JP. Cephaloridine prophylaxis in resection of the large intestine. Aust NZ J Surg 49: 434–437, 1981
  • Moesgaard F, Lykkegaard-Nielsen M, Justesen T. Experimental animal model of surgical wound infection applicable to antibiotic prophylaxis. Eur J Clin Microbiol 2: 459–462, 1983
  • Leaper DJ, Page RE, Rosenberg IL, Wilson DH, Goligher JC. A controlled study comparing the conventional treatment of idiopathic anorectal abscess with that of incision, curettage and primary suture under systemic antibiotic cover. Dis Colon Rectum 19: 46–50, 1976
  • Higgins AF, Lewis A, Noone P, Hole ML. Single and multiple dose of co-trimoxazole and metronidazole in colorectal surgery. Br J Surg 67: 90–92, 1980
  • Giercksky K, Danielsen S, Garberg O, Grüner OPN, Holter O, Johnson JA, Nygaard K, Ofstad E, Stadaas J, Viddal KO. A single dose tinidazole and doxycycline prophylaxis in elective surgery of colon and rectum. Ann Surg 195: 227–231, 1982

References

  • Mills OH, Kligman AM. Drugs that are ineffective in the treatment of acne vulgaris. Br J Dermatol 108: 371–374, 1983
  • Ad hoc Committee Report. Systemic antibiotics for treatment of acne vulgaris. Arch Derm 111: 1630–1636, 1975
  • Stoughton RB. Topical antibiotics for acne vulgaris. Arch Dermatol 115: 486–489, 1979
  • Guin JD. Topical clindamycin: A double-blind study comparing clindamycin phosphate with clindamycin hydrochloride. Int J Dermatol 18: 164–165, 1979
  • Becker LE, Bergstresser PR, Whiting DA. Topical clindamycin therapy for acne vulgaris. Arch Dermatol 117: 482–485, 1981
  • Stoughton RB, Resh W. Topical clindamycin in the control of acne vulgans. Cutis 17: 551–554, 1976
  • Thomsen RJ, Stranieri A, Knutson D, Strauss JS. Topical clindamycin treatment of acne. Arch Dermatol 116: 1031–1034, 1980
  • Gratton D, Raymond GP, Guertin-Larochelle S. Topical clindamycin versus systemic tetracycline in the treatment of acne. J Am Acad Dermatol 7: 50–53, 1982
  • Stoughton RB, Cornell RC, Gange RW, Walter JF. Double-blind comparison of topical 1% clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris. Cutis 26: 424, 1980
  • Milstone EB, McDonald AJ, Scholhamer CF. Pseudomembranous colitis after topical application of clindamycin. Arch Dermatol 117: 154–155, 1981
  • Plewig G, Schöpf E. Anti-inflammatory effects of antimicrobial agents: An in vivo study. J Invest Dermatol 65: 532–536, 1975
  • Esterly N, Furey N, Flanagan L. The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol 70: 51–55, 1978
  • Guin JD, Lummis WL. Comedonal levels of free clindamycin following topical treatment with a 1 % solution of clindamycin phosphate. J Am Acad Dermatol 7: 265–268, 1982
  • Guin JD, Reynolds R, Gielerak PL. Penetration of topical clindamycin into comedones. J Am Acad Dermatol 3: 153–156, 1980
  • Resh W, Stoughton RB. Topically applied antibiotics in acne vulgaris: Clinical response and suppression of Corynebacterium acnes in open comedones. Arch Dermatol 112: 182–184, 1976
  • Gloor M, Kraft H, Franke M. Effectiveness of topically applied antibiotics on anaerobic bactena in the pilosebaceous duct. Dermatologica 157: 96, 1978
  • Leyden JJ, McGinley K, Mills OH, Kligman AM. Topical antibiotics and topical antimicrobials in acne therapy. Acta Derm Venereol (Stockholm) 60, Suppl. 89: 75, 1980
  • Algra RJ, Rosen T, Waisman M. Topical clindamycin in acne vulgaris: Safety and stability. Arch Dermatol 113: 1390–1391, 1977

References

  • Gratton D, Raymond GP, Guertin-Larochelle S. Topical clindamycin versus systemic tetracycline in the treatment of acne. J Am Acad Dermatol 7: 50–53, 1982
  • Resh W, Stoughton RB. Topically applied antibiotics in acne vulgaris. Arch Dermatol 112: 182–184, 1976
  • Padilla RS, McCabe JM, Becker LE. Topical tetracycline hydrochloride vs topical clindamycin phosphate in the treatment of acne. Internat J Dermatol 20: 445–448, 1981
  • Eady EA, Holland KT, Cunliffe WJ. Should topical antibiotics be used for the treatment of acne vulgaris. Br J Dermatol 107: 235–246, 1982
  • Bollgren I, Nord CE, Pettersson L. Periurethral anaerobic microflora in girls highly susceptible to urinary tract infection. J Urology 125: 715–719, 1981
  • Heimdahl A, Nord CE. Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scand J Infect Dis 11: 233–242, 1979
  • Aronsson B, Möllby R, Nord CE. Clostridium difficile and antibiotic associated diarrhoea in Sweden. Scand J Infect Dis 35: 53–58, 1982
  • Heimdahl A, Nord CE. Influence of doxycycline on the normal human flora and colonization of the oral cavity and colon. Scand J Infect Dis 15: 293–302, 1983
  • Milstone EB, McDonald AJ, Schulhamer Jr CF. Pseudomembranous colitis after topical application of clindamycin. Arch Dermatol 117: 154–155, 1981
  • Voron DA. Systemic absorption of topical clindamycin. Arch Dermatol 114: 798, 1978
  • Rietschel RL, Duncan SH. Clindamycin phosphate used in combination with tretinoin in the treatment of acne. Internat J Dermatol 22: 41–43, 1983
  • Heimdahl A, Nord, CE. Effect of erythromycin and clindamycin on the indigenous human anaerobic flora and new colonization of the gastrointestinal tract. Eur J Clin Microbiol 1: 39–47, 1982
  • Leyden JJ, McGinley KJ, Cavalieri S. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 8: 41–45, 1983
  • Stoughton RB, Rech W. Topical clindamycin in the control of acne vulgaris. Cutis 17: 551–554, 1976
  • Crawford WW, Crawford IP, Stoughton RB. Laboratory inductions and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes. J Invest Dermatol 72: 187–190, 1979

References

  • Bartlett JG, Onderdonk AB, Louie TJ, Kasper DL, Gorbach SL. A review: Lessons from an animal model of intra-abdominal sepsis. Arch Surg 113: 853–857, 1978
  • Onderdonk AB, Bartlett JG, Louie T, Sullivan-Seigler N, Gorbach SL. Microbial synergy in experimental intra-abdominal abscess. Infect Immun 13: 22–26, 1976
  • Onderdonk AB, Kasper DL, Cisneros RL, Bartlett JG. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: Comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis 136: 82–89, 1977
  • Simon GL, Klempner MS, Kasper DL, Gorbach SL. Alterations in opsonophagic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide. J Infect Dis 145: 72–77, 1982
  • Kelly MJ, Warren RE. The value of an operative wound swab sent in transport medium in the predication of later clinical wound infection. A controlled clinical and bacteriological evaluation. Br J Surg 65: 81, 1978
  • Thadepalli H, Gorbach SL, Broido PW. Abdominal trauma, anaerobes, and antibiotics. Surg Gynecol Obstet 137: 270–276, 1973
  • Tally FP, McGowan K, Kellum JM, Gorbach SL, O'Donnell TF. A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis. Ann Surg 193: 318–323, 1981
  • Drusano GL, Warren JW, Saah AJ, Caplan ES, Tenney JH, Hansen S, Granados J, Standiford HC, Miller EH Jr. A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections. Surg Gynecol Obstet 154: 715–720, 1982
  • Klastersky J, Coppens L, Mombelli G. Anaerobic infection in cancer patients: Comparative evaluation of clindamycin and cefoxitin. Antimicrob Agents Chemother 16: 366–371, 1979
  • Smith JA, Skidmore AG, Forward AD, Clarke AM, Sutherland E. Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis. Ann Surg 192: 213–220, 1980
  • Collier J, Colhoun EM, Hill PL. A multicenter comparison of clindamycin and metronidazole in the treatment of anaerobic infections. Scand J Infect Dis 26 ( Suppl): 96–100, 1981
  • Berne TV, Yellin AW, Appleman MD, Haseltine PNR. Antibiotic management of surgically treated gangrenous or perforated appendicitis: Comparison of gentamicin and clindamycin versus cefamandole versus cefoperazone. Am J Surg 144: 8–12, 1982
  • Chow AW, Ota JK, Guze LG. Clindamycin plus gentamicin as expectant therapy for presumed mixed infections. Can Med Assoc J 115: 1225–1229, 1976
  • Leigh DA, Simmons K, Williams S. The treatment of abdominal and gynecological infections with parenteral clindamycin phosphate. J Antimicrob Chemother 3: 493–500, 1977
  • Swenson RM, Michaelson TC, Daly MJ, Spalding EH. Clindamycin in infections of the female genital tract. Obstet Gynecol 44: 699–702, 1974
  • Ledger WJ, Gee CL, Lewis WP, Bobbit JR. Comparison of clindamycin and chloramphenicol in treatment of serious infections of the female genital tract. J Infect Dis 135 ( Suppl): S30–S34, 1977
  • Harding GKM, Buckwold FJ, Ronald AR, Marrie TJ, Brunton S, Koss JC, Gurwith MJ, Albritton WL. Prospective, randomized comparative study of clindamycin, chloramphenicol, and ticarcillin, each in combination with gentamicin, in therapy for intra-abdominal and female genital tract sepsis. J Infect Dis 142: 384–393, 1980
  • Thadepalli H, Huang JT. Treatment of anaerobic infections: Carbenicillin alone compared with clindamycin and gentamicin. Curr Ther Res 22: 549–555, 1977
  • diZerega G, Yonekura L, Roy S, Nakamura RM, Ledger WJ. A comparison of clindamycin-gentamicin and penicillin-gentamicin in the treatment of postcesarean endomyometritis. Am J Obstet Gynecol 134: 238–243, 1979
  • Landers DW, Sweet RL. Contemporary management of tubo-ovarium abscesses. Rev Infect Dis 5: 876–884, 1983

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.